INTU vs MELI: Which Is the Better Buy?

Side-by-side comparison of Intuit Inc. and MercadoLibre, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-08.
Intuit Inc. · Technology
$396.57
+37.7% upside to fair value
High Conviction Grade A-
VS
MercadoLibre, Inc. · Consumer Cyclical
$1,767.42
+41.4% upside to fair value
High Conviction Grade A
QuantHub Verdict
MELI has more upside to fair value (+41.4%). INTU trades at a lower forward P/E (19.5x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric INTU MELI
Current Price $396.57 $1,767.42
Fair Value Estimate $546.00 $2,500.00
Upside to Fair Value +37.7% +41.4%
Market Cap $110.4B $89.6B
Forward P/E 19.5x 35.0x
EV / EBITDA 19.0x 18.5x
Price / Sales 5.9x 3.1x
Price / FCF 18.1x 8.9x
Revenue Growth YoY +15.6% +39.1%
Gross Margin 80.8% 44.5%
Operating Margin 26.1% 11.1%
Return on Equity 19.6% 33.7%
Dividend Yield 1.17% 0%
FCF Yield 5.51% 12.1%
Analyst Consensus Buy Strong Buy
Investment Thesis
INTU — Intuit Inc.
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
MELI — MercadoLibre, Inc.
MercadoLibre is the dominant e-commerce and fintech ecosystem across Latin America, operating the largest marketplace and digital payments platform in a region with 670M+ people where e-commerce penetration is still under 15%. Revenue grew 39% to $28.9B in FY2025 with $10.8B in free cash flow — a 12% FCF yield at current prices. The company is trading at its 5-year P/S minimum (3.1x) and P/FCF mi…
Accumulation Zones
Metric INTU MELI
Zone Low $410.00 $1,875.00
Zone High $464.00 $2,125.00
In Buy Zone? Yes Yes
← INTU Research    MELI Research →    All Research